Klebsiella pneumoniae colonizes mucosal surfaces of healthy humans and is responsible
for one third of all Gram-negative infections in hospitalized patients. K. pneumoniae is …

Antibacterial resistance is a prominent issue with monotherapy often leading to treatment
failure in serious infections. Many mechanisms can lead to antibacterial resistance including …

Background Aminoglycoside-containing regimens may be an effective treatment option for
infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-Kp), but …

Infections with drug-resistant bacteria have become one of the greatest public health
challenges, and K. pneumoniae is among the top six drug-resistant bacteria. K. pneumoniae …

The study investigated carbapenemase-producing Klebsiella pneumoniae (CPKP) isolates
of patients in an intensive care unit (ICU) in a public hospital in the KwaZulu-Natal province …

Carbapenem-resistant Acinetobacter baumannii (CRAB) can cause serious infections that
are associated with high mortality rates. During the course of an infection, many CRAB …

Antibiotic combinations, including ceftazidime/avibactam (CAZ/AVI), are frequently
employed to combat KPC-producing Klebsiella pneumoniae (KPC-Kp), though such …

Background Ceftazidime/avibactam is one of the preferred treatment options for
carbapenem-resistant Enterobacterales (CRE). However, the benefit of combining …

Purpose Through long-term and large sample size statistical analysis, we revealed the
pattern of Klebsiella pneumoniae (KP) infection and drug resistance and provided …

Background: The emergence of antibiotic resistance is one of the major issues facing global
healthcare systems. Objectives: This study aims to determine the prevalence and resistance …